These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10906324)

  • 1. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes.
    Wixler V; Geerts D; Laplantine E; Westhoff D; Smyth N; Aumailley M; Sonnenberg A; Paulsson M
    J Biol Chem; 2000 Oct; 275(43):33669-78. PubMed ID: 10906324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha7beta1 integrin receptor.
    Samson T; Smyth N; Janetzky S; Wendler O; Müller JM; Schüle R; von der Mark H; von der Mark K; Wixler V
    J Biol Chem; 2004 Jul; 279(27):28641-52. PubMed ID: 15117962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.
    McLoughlin P; Ehler E; Carlile G; Licht JD; Schäfer BW
    J Biol Chem; 2002 Oct; 277(40):37045-53. PubMed ID: 12145280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis.
    Scholl FA; McLoughlin P; Ehler E; de Giovanni C; Schäfer BW
    J Cell Biol; 2000 Oct; 151(3):495-506. PubMed ID: 11062252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LIM-only protein FHL2 is a negative regulator of E4F1.
    Paul C; Lacroix M; Iankova I; Julien E; Schäfer BW; Labalette C; Wei Y; Le Cam A; Le Cam L; Sardet C
    Oncogene; 2006 Sep; 25(40):5475-84. PubMed ID: 16652157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein.
    Tanahashi H; Tabira T
    Hum Mol Genet; 2000 Sep; 9(15):2281-9. PubMed ID: 11001931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ.
    Arber S; Caroni P
    Genes Dev; 1996 Feb; 10(3):289-300. PubMed ID: 8595880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interactions of the LIM-only protein FHL2 and functional implication of the interactions relevant in cardiovascular disease.
    Tran MK; Kurakula K; Koenis DS; de Vries CJ
    Biochim Biophys Acta; 2016 Feb; 1863(2):219-28. PubMed ID: 26548523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma.
    Genini M; Schwalbe P; Scholl FA; Remppis A; Mattei MG; Schäfer BW
    DNA Cell Biol; 1997 Apr; 16(4):433-42. PubMed ID: 9150430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP-associated factor 1 interacts with and attenuates the trans-activity of four and a Half LIM protein 2.
    Zhang W; Yang Y; Jiang B; Peng J; Tu S; Sardet C; Zhang Y; Pang R; Hung IF; Tan VP; Lam CS; Wang J; Wong BC
    Mol Carcinog; 2011 Mar; 50(3):199-207. PubMed ID: 21104993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET).
    Li HY; Ng EK; Lee SM; Kotaka M; Tsui SK; Lee CY; Fung KP; Waye MM
    J Cell Biochem; 2001; 80(3):293-303. PubMed ID: 11135358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
    Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
    Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex.
    Mille F; Thibert C; Fombonne J; Rama N; Guix C; Hayashi H; Corset V; Reed JC; Mehlen P
    Nat Cell Biol; 2009 Jun; 11(6):739-46. PubMed ID: 19465923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference silencing of DRAL affects processing of amyloid precursor protein.
    Tanahashi H; Yoshioka K
    Neurosci Lett; 2008 Jul; 439(3):293-7. PubMed ID: 18534756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
    Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).
    Amaar YG; Thompson GR; Linkhart TA; Chen ST; Baylink DJ; Mohan S
    J Biol Chem; 2002 Apr; 277(14):12053-60. PubMed ID: 11821401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
    Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
    Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.